MYCN and neuroblastoma: Recently, Westermann and colleagues reported 4 subgroups in neuroblastoma, including MYCN-amplified (MYCN), MYCN non-amplified high-risk (MNA-HR), MYCN non-amplified low-risk (MNA-LR) and mesenchymal (MES) [41].